Gursh Kundan

Abraxas is an energy transition developer, focused on decarbonizing hard-to-abate sectors and creating value by solving the current and future challenges of the energy transition. Our broad mandate allows us to see opportunities across technologies and geographies. Our teams experience and multi-disciplinary approach create value.

Based in Denver, Colorado, AngelMD is a healthcare-focused investing platform that connects leading healthcare startups from all over the world with investors, physicians, industry executives and private capital to create a more efficient path from investment to exit while de-risking investments in the process, leading to better outcomes. We welcome all healthcare startups to create a profile on our site. Even if you are not currently looking for funding, create a profile to be connected to industry thought leaders and valuable resources as you grow your business.

Abraxas is an energy transition developer, focused on decarbonizing hard-to-abate sectors and creating value by solving the current and future challenges of the energy transition. Our broad mandate allows us to see opportunities across technologies and geographies. Our teams experience and multi-disciplinary approach create value.

Polisano Pharmaceuticals is a privately held pharmaceutical company. Our vision is to become a leading global company that contributes to improving people’s health by researching, developing, manufacturing and supplying high-quality solutions for patients with diverse medical needs. Our principles are at the core of what we do, and guide us through every stage of our processes: - Innovation: we constantly develop new pharmaceutical formulas; - Diversity: we cover all major therapeutic areas; - Addressability: we aim to reach as many people as possible, without compromising quality; With an established 15-year business footprint, more than 130 employees and a 33,000 sq.m. facility equipped with state-of-the-art manufacturing units and research laboratories, we offer a full range of quality pharmaceutical products and services in all major therapeutic areas. Over the last 10 years, Polisano Pharmaceuticals has invested more than 70 million euros in production lines and equipment. The current management team of Polisano Pharmaceuticals: Marius Cherecheș - President of the Board Alina Veronica Magdău - CEO Vivian Diaconescu - Chief Commercial & Business Development Officer Simona Naghiu - Operations Director

Polisano Pharmaceuticals is a privately held pharmaceutical company. Our vision is to become a leading global company that contributes to improving people’s health by researching, developing, manufacturing and supplying high-quality solutions for patients with diverse medical needs. Our principles are at the core of what we do, and guide us through every stage of our processes: - Innovation: we constantly develop new pharmaceutical formulas; - Diversity: we cover all major therapeutic areas; - Addressability: we aim to reach as many people as possible, without compromising quality; With an established 15-year business footprint, more than 130 employees and a 33,000 sq.m. facility equipped with state-of-the-art manufacturing units and research laboratories, we offer a full range of quality pharmaceutical products and services in all major therapeutic areas. Over the last 10 years, Polisano Pharmaceuticals has invested more than 70 million euros in production lines and equipment. The current management team of Polisano Pharmaceuticals: Marius Cherecheș - President of the Board Alina Veronica Magdău - CEO Vivian Diaconescu - Chief Commercial & Business Development Officer Simona Naghiu - Operations Director